Skip to main content

Day: February 14, 2022

Eos Energy Enterprises Appoints Chief Accounting Officer

EDISON, N.J., Feb. 14, 2022 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos”), a leading provider of safe, scalable, efficient, and sustainable zinc-based energy storage systems, today announced that John (“Jay”) Tedone has been appointed Chief Accounting Officer. Tedone, who has 25 years of experience in various financial leadership roles, will oversee the accounting, tax and SEC reporting functions at Eos. “As our company evolves and our needs become more complex, it will become increasingly critical to have experienced, dynamic professionals on our team,” said Joe Mastrangelo, Chief Executive Officer of Eos. “Jay will serve as a key resource in our Finance Department and will ensure that we continue to bring accountability and transparency to our shareholders. We are thrilled to continue to attract top-level...

Continue reading

Samba TV and PubMatic Launch Australia Partnership to Deliver Programmatic Omniscreen TV Audience Targeting

Announcement marks continued growth and expansion for Samba TV in the Australian market SAN FRANCISCO, Feb. 15, 2022 (GLOBE NEWSWIRE) — Samba TV, a leading global provider of omniscreen advertising and analytics, today announced a partnership together with PubMatic (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, to bring programmatic omniscreen TV audience targeting to Australia. The announcement marks an expansion of Samba TV’s existing European partnership with PubMatic. Samba TV’s extensive first-party Connected TV data will be integrated with PubMatic’s programmatic platform to provide media buyers with advanced omniscreen targeting capabilities across Australia, a top 10 advertising market globally. The combination of Samba TV’s first-party TV data, the largest...

Continue reading

R1 RCM to Present at the SVB Leerink 11th Annual Global Healthcare Conference

MURRAY, Utah, Feb. 14, 2022 (GLOBE NEWSWIRE) — R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the SVB Leerink 11th Annual Global Healthcare Conference on Friday, February 18, 2022 at 1:00 pm ET. A live audio webcast of the presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay of the webcast will be available for 90 days following the live webcast. About R1 RCM R1 is a leading provider of technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. R1’s proven and scalable operating models seamlessly complement a healthcare organization’s...

Continue reading

Johnson Outdoors Announces New Vice President of Global Operations and Supply Chain

RACINE, Wis., Feb. 14, 2022 (GLOBE NEWSWIRE) — Johnson Outdoors Inc. (Nasdaq:JOUT), a leading innovator of outdoor recreation equipment and technology, today announced the selection of Terry Troutman as the new Vice President, Global Operations and Supply Chain. Mr. Troutman will report to Helen Johnson-Leipold, CEO, Johnson Outdoors and hold a seat on the Company’s Executive Committee. In this new role, Troutman is responsible for overseeing the global, system-wide operations and leading the carbon footprint initiatives for the company. Terry brings a wealth of experience and proven success in global operations including driving business results in strategic and tactical leadership, supply chain, manufacturing, logistics, inventory and demand planning, customer service and transportation. He joins the company from Instant Brands...

Continue reading

NRC Health Declares Quarterly Dividend

Lincoln, Nebraska, Feb. 14, 2022 (GLOBE NEWSWIRE) — National Research Corporation, dba NRC Health, (NASDAQ:NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.24 (twenty-four cents) per share  payable Friday, April 15, 2022, to shareholders of record as of the close of business on Thursday, March 31, 2022.                For more than 40 years, National Research Corporation has been a leading provider of analytics and insights that facilitate measurement and improvement of Human Understanding.CONTACT: Kevin R. Karas Chief Financial Officer 402-475-2525

Continue reading

Sonoco Announces Changes to Board of Directors

HARTSVILLE, S.C., Feb. 14, 2022 (GLOBE NEWSWIRE) — Sonoco (NYSE: SON), one of the largest global sustainable packaging companies, today announced that two members of the Company’s Board of Directors will be leaving. Marc D. Oken, 75, chairman and founder of Falfurrias Capital Partners, a Charlotte, N.C., private equity firm, has reached the Board’s mandatory retirement age and will not stand for reelection at the Company’s 2022 Annual General Meeting. Oken joined the board in 2006 and serves on the Company’s Executive Committee as well as the Executive Compensation, Audit and Corporate Governance and Nominating committees. In addition, Lloyd M. Yates, 61, who was recently named President and Chief Executive Officer of NiSource, Inc. (NYSE: NI), a Merrillville, IN, energy holding company, extended his resignation to Sonoco’s Board,...

Continue reading

Ascot Resources Ltd. Announces C$56 Million Bought Deal Financing

Not for distribution to U.S. news wire services or dissemination in the United States. VANCOUVER, British Columbia, Feb. 14, 2022 (GLOBE NEWSWIRE) — Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) has announced today that it has entered into an agreement with a syndicate of underwriters co-led by Desjardins Capital Markets and BMO Capital Markets, under which the underwriters have agreed to buy on a bought deal basis approximately C$56 million of common shares (the “Common Shares”) and units of the Company (the “Offering”). The Offering will consist of a combination of (i) 28,610,000 Common Shares (the “Offered Shares”) of the Company at a price of C$1.02 per Offered Share for gross proceeds of C$29,182,200; (ii) 5,100,000 hard dollar units of the Company (the “HD Units”) at a price of C$1.02 per HD Unit...

Continue reading

CPS Announces Fourth Quarter And Full Year 2021 Earnings

Pretax income of $24.4 million for the fourth quarter and $65.7 million for 2021 Net income of $19.0 million, or $0.71 per diluted share for the fourth quarter Net income of $47.5 million, or $1.84 per diluted share for 2021 New contract purchases of $1.146 billion for the full year 2021  LAS VEGAS, NV, Feb. 14, 2022 (GLOBE NEWSWIRE) — Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced earnings of $19.0 million, or $0.71 per diluted share, for its fourth quarter ended December 31, 2021. This compares to a net income of $4.1 million, or $0.17 per diluted share, in the fourth quarter of 2020. The results for the fourth quarter of 2021 include a net tax benefit of $680,000 related to revaluation of the Company’s net operating losses and other tax adjustments. Without the benefit, net income...

Continue reading

Trupanion Brings Together Experts for Fun and Informative Smile-Sharing Online Event on the Importance of Pet Dental Health

Seattle, Feb. 14, 2022 (GLOBE NEWSWIRE) — Trupanion, a leader in medical insurance for cats and dogs, will host a smile-sharing online event aimed at providing pet parents valuable information on the importance of pet dental health. The live session takes place on Thursday, February 17 at 5:00 p.m. PST / 8:00 p.m. EST. Dr. Steve Weinrauch founder of MightyVet & chief veterinary officer at Trupanion will be joined by another expert in dental health, Dr. Patrick Vall. Dr. Vall is owner of Animal Dental Care and Oral Surgery, which serves clients in Colorado and Wyoming. This smile-sharing online event is intended to be a lively and fun session with information on how pets can live longer, happier lives – starting with their teeth. WHO: Dr. Steve Weinrauch, BVMS, MRCVS, chief veterinary officer at Trupanion and, founder of MightyVet,...

Continue reading

Advaxis Reports Fiscal Year 2021 Financial Results and Provides a Business Update

MONMOUTH JUNCTION, N.J., Feb. 14, 2022 (GLOBE NEWSWIRE) — Advaxis, Inc. (OTCQX: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announces its financial results for the fiscal year ended October 31, 2021 and provides a business update. Fiscal Year 2021 and Recent Key Accomplishments: Presented updated clinical data from ongoing Phase 1/2 Trial of ADXS-503 in NSCLCIn Part B combination arma second partial response was observed overall response rate was 15% and disease control rate was 46%In Part C combination arm in newly diagnosed subjectsdisease control rate of 67% was observedInitiated Phase 1 trial of ADXS-504 for the treatment of early prostate cancerManagement Commentary“Fiscal year 2021 was a busy year for Advaxis, with important...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.